Bausch Health Companies | VRX - Los Gastos Financieros De La Deuda





Los Gastos Financieros De La Deuda Cambio Fecha
Amgen USD 657M 4M 2026-03
ANI Pharmaceuticals USD 4.41M 316K 2025-12
Aurora Cannabis CAD 230K 1.88M 2026-03
Bausch Health Companies USD 397M 15M 2025-12
Biogen USD 72.6M 12.6M 2025-06
Bristol-Myers Squibb USD 411M 21M 2026-03
Canopy Growth CAD 12.31M 4.97M 2026-03
Corcept Therapeutics USD 814.88M 809.46M 2026-03
Danaher USD 107M 44M 2026-06
Drreddys Laboratories INR 1.06B 113M 2026-03
Eli Lilly USD 114.7M 134.3M 2025-09
Gilead Sciences USD 240M 15M 2026-03
Nektar Therapeutics USD 9.77M 3.75M 2025-12
Novo Nordisk DKK 1.53B 3.43B 2025-09
Pacira USD 3.7M 193K 2026-03
Perrigo USD 7.98B 7.94B 2026-03
Phibro Animal Health USD 11.91M 191K 2025-12
Prestige Brands USD 10.67M 636K 2025-12
Supernus Pharmaceuticals USD 910K 278K 2023-06
Vertex Pharmaceuticals USD 3.3M 0 2025-12
Zoetis USD 62M 5M 2026-03